Lucia is co-founder and CEO of Osmind. Prior to Osmind, she led business and operations at Verge Genomics, a next generation biotechnology company leveraging artificial intelligence for central nervous system diseases such as ALS and Parkinson’s.

‍

Before Verge, Lucia was a growth investor at Warburg Pincus, where she made investments to help scale innovative healthcare technology companies such as those developing Electronic Health Records systems. Lucia started her career as an investment banker advising the world’s largest pharmaceutical companies while at Evercore.
‍

Lucia graduated Yale with a B.S. in Chemistry and earned an MBA at Stanford, where she was also awarded a Certificate in Public Management and Social Innovation for her dedication to social impact.
‍
Lucia has devoted her career to improving healthcare through driving change at the intersection of life sciences, technology, and data. She has been named to Forbes 30 under 30 for her innovative work in healthcare.

‍